Attenuation of TORC1 signaling delays replicative and oncogenic RAS-induced senescence
- 15 June 2012
- journal article
- Published by Informa UK Limited in Cell Cycle
- Vol. 11 (12), 2391-2401
- https://doi.org/10.4161/cc.20683
Abstract
Numerous stimuli, including oncogenic signaling, DNA damage or eroded telomeres trigger proliferative arrest, termed cellular senescence. Accumulating evidence suggests that cellular senescence is a potent barrier to tumorigenesis in vivo, however oncogene induced senescence can also promote cellular transformation.1,2 Several oncogenes, whose overexpression results in cellular senescence, converge on the TOR (target of rapamycin) pathway. We therefore examined whether attenuation of TOR results in delay or reversal of cellular senescence. By using primary human fibroblasts undergoing either replicative or oncogenic RAS-induced senescence, we demonstrated that senescence can be delayed, and some aspects of senescence can be reversed by inhibition of TOR, using either the TOR inhibitor rapamycin or by depletion of TORC1 (TOR Complex 1). Depletion of TORC2 fails to affect the course of replicative or RAS-induced senescence. Overexpression of REDD1 (Regulated in DNA Damage Response and Development), a negative regulator of TORC1, delays the onset of replicative senescence. These results indicate that TORC1 is an integral component of the signaling pathway that mediates cellular senescence.Keywords
This publication has 98 references indexed in Scilit:
- Activation of the PIK3CA/AKT Pathway Suppresses Senescence Induced by an Activated RAS Oncogene to Promote TumorigenesisMolecular Cell, 2011
- p38MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotypeThe EMBO Journal, 2011
- TBK1 Directly Engages Akt/PKB Survival Signaling to Support Oncogenic TransformationMolecular Cell, 2011
- Phosphatidylinositol 3-Kinase: The OncoproteinPublished by Springer Science and Business Media LLC ,2010
- PI3K: From the Bench to the Clinic and BackPublished by Springer Science and Business Media LLC ,2010
- mTOR and cancer: many loops in one pathwayCurrent Opinion in Cell Biology, 2009
- Emerging common themes in regulation of PIKKs and PI3KsThe EMBO Journal, 2009
- The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase CThe EMBO Journal, 2008
- AKT/PKB Signaling: Navigating DownstreamCell, 2007
- mTOR Interacts with Raptor to Form a Nutrient-Sensitive Complex that Signals to the Cell Growth MachineryCell, 2002